Previously, MR methods have been used to investigate the causal relationship of circulating protein biomarkers on ischemic stroke and the impact of angiopoietin-like protein 3 (ANGPTL3) and 4 (ANGPTL4) inhibition of lipoprotein lipase (LPL) on CVD [50]. This evidence concerns the gene ANGPTL3 and ischemic stroke.